Evidence map›Paper›PMID 37946220›Full record

Trial reportBMC psychiatry2023

Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial.

Reham M Elhossiny, Heba H Elshahawy, Hanan M Mohamed, Reham I Abdelmageed

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04167995 early_phase1completednot on this map

Assessment of Probiotic Strain Lactobacillus Acidophilus LB Supplementation as Adjunctive Management of Attention-deficit Hyperactivity Disorder in Children and Adolescents: a Randomized Controlled Clinical Trial

TypeinterventionalSponsorAin Shams UniversityRan2020 to 2021Enrolled80ConditionsInattentive, Hyperactivity, ImpulsivityArmsProbiotic Formula lacteal forte
NCT06376331 phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder and Its Comorbidities

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2024 to 2027Enrolled50ConditionsAttention-deficit/Hyperactivity DisorderArmswashed microbiota transplantation
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Add-OnNutrients · 2024
    Trial
  6. Trial
  7. Article
  8. Gut Microbiome and ADHD: A Narrative Review of Clinical Evidence and Practice Implications.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. [The microbiota-gut-brain axis in childhood attention-deficit/hyperactivity disorder: mechanisms and therapeutic advances].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Reham M ElhossinyPediatrics Department, Faculty of Medicine, Ain Shams University, Abbassya Square, Cairo, Egypt.
Heba H ElshahawyDepartment of Neuropsychiatry, Faculty of Medicine, Okasha Institue of Psychiatry, Ain Shams University, Cairo, Egypt.
Hanan M MohamedPediatrics Department, Faculty of Medicine, Ain Shams University, Abbassya Square, Cairo, Egypt.
Reham I AbdelmageedPediatrics Department, Faculty of Medicine, Ain Shams University, Abbassya Square, Cairo, Egypt. rehamibrahim@med.asu.edu.eg.ORCID 0000-0001-6801-5178
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was designed to examine the possible efficacy of the probiotic strain Lactobacillus acidophilus LB (Lacteol Fort) on attention-deficit/hyperactivity disorder (ADHD) symptomatology and evaluate its influence on cognition function.

methodsIn this randomized controlled trial, 80 children and adolescents with ADHD diagnosis, aged 6-16 years, were included. The participants were randomly assigned to two groups: one group received probiotics plus atomoxetine, whereas the other group received atomoxetine only. ADHD symptomatology was assessed using the Conners Parent Rating Scale-Revised Long Version (CPRS-R-L) and Child Behavioral Checklist (CBCL/6-18). The participants were evaluated for their vigilance and executive function using Conner's Continuous Performance Test (CPT) and Wisconsin Card Sort Test (WCST). Both groups were assessed at the beginning of the study and the end of the twelve weeks.

resultsThe probiotic group comprised 36 patients, whereas the control group comprised 40 patients in the final analysis after four patients dropped out of the trial. After 3 months of probiotic supplementation, a significant improvement in the CPRS-R-L and CBCL total T scores was observed compared with those in the control group (p = 0.032, 0.024, respectively). Additionally, the probiotic group demonstrated improved focus attention (target accuracy rate and omission errors;p = 0.02, 0.043, respectively) compared with the control group. An analysis of the Wisconsin Card Sorting Test (WCST) performance demonstrated that the probiotic group had significantly lower perseverative (p = 0.017) and non-perseverative errors (p = 0.044) but no significant differences compared to the control group.

conclusionLactobacillus acidophilus LB supplementation combined with atomoxetine for 3 months had a beneficial impact on ADHD symptomology and a favorable influence on cognitive performance. As a result, the efficacy of probiotics as an adjunctive treatment for managing ADHD may be promising.

trial registrationClinicalTrials.gov (identifier: NCT04167995). Registration date: 19-11-2019.

Indexed as

Attention Deficit Disorder with HyperactivityProbioticsAdolescentAtomoxetine HydrochlorideChildDietary SupplementsHumansLactobacillusLactobacillus acidophilusTreatment OutcomeAtomoxetine HydrochlorideADHDAdolescentsAttention-deficit/hyperactivity disorderChildrenCognitionLactobacillus acidophilus LBProbiotic

Identifiers

PMID37946220
PMCPMC10636814
OpenAlexW4388523063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.